Latest Biotechnology, Pharmaceutical and Healthcare News from SmartBrief

09:24 EST 19th November 2017 | BioPortfolio

Here are the most relevant search results for "SmartBrief" found in our extensive news archives from over 250 global news sources.

More Information about SmartBrief on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about SmartBrief for you to read. Along with our medical data and news we also list SmartBrief Clinical Trials, which are updated daily. BioPortfolio also has a large database of SmartBrief Companies for you to search.

Showing News Articles 1–25 of 3,600+ from SmartBrief

Friday 17th November 2017

A man may truly live in his dreams, his noblest dreams, but only, only if he is worthy of those dreams.

Harlan Ellison, writer

Brazil to adopt corn, cane-derived biofuel concept

Brazilian ethanol producers have been assessing the adoption of a concept that uses corn and cane in the production of biofue -More- 

Biotech mosquitoes to be tested in India

Scientists at the University of California's San Diego and Irvine campuses will use a $70 million grant from India's Tata Tru -More- 


Win a company presentation and registration at the BIO CEO and Investor Conference in NYC on Feb. 12-13! Enter by Nov.  -More- 

Merck, Cue Biopharma to collaborate on autoimmune disease studies

Using Cue Biopharma's Cue Biologics platform, the company will work with Merck to develop treatments for autoimmune diseases. -More- 

Bluebird bio announces first patient in trial of beta-thalassemia candidate

Bluebird bio's Phase III trial to assess its lead candidate, LentiGlobin, in transfusion-dependent beta-thalassemia patients  -More- 

Xarelto reduces amputation risk from PAD, deaths from CAD

Johnson & Johnson's blood thinner Xarelto, or rivaroxaban, taken with aspirin, cut the rate of major amputations in patients  -More- 

Novartis' Kisqali backed by NICE for advanced breast cancer

The National Institute for Health and Care Excellence recommended for use Novartis' Kisqali, or ribociclib, in combination wi -More- 

GSK's subcutaneous formulation of Benlysta granted EU nod

The European Commission granted approval for a new subcutaneous formulation of GlaxoSmithKline's Benlysta, or belimumab, as a -More- 

Healios enrolls, treats first patient in Japan for stem cell therapy trial

Healios KK said it has enrolled and treated the first patient in Japan for its TREASURE study to test its adult stem cell reg -More- 

Ultragenyx's Sly syndrome drug approved by FDA

Ultragenyx Pharmaceutical's Mepsevii, or vestronidase alfa-vjbk, was approved by the FDA as a treatment for patients with muc -More- 

Combination Products: Regulations, Guidances & Rules

Nov. 28-29 | Washington, D.C.Join us for a day and a half on combination products.  -More- 

Final guidance on UDI marking requirements issued by FDA

A guidance on direct marking of medical devices with a unique device identifier was finalized by the FDA.  -More- 

HHS urged by House panel to secure medical device cybersecurity

HHS should ensure the cybersecurity of medical devices by requiring manufacturers to provide a list of third-party software c -More- 

Nevro's spinal cord stimulator secures MR-conditional nod from EU

European regulators granted Nevro MR-conditional CE mark approval for its Senza spinal cord stimulator for chronic pain treat -More- 

Japan OKs radiotherapy cancer treatment system from Varian Medical

Varian Medical's Halcyon image-guided volumetric intensity modulated radiotherapy cancer treatment system was granted Shonin  -More- 

Titan Medical's robotic surgical platform used in preclinical trial

Columbia University Medical Center's surgical simulation center in New York was the first to perform a procedure using Titan  -More- 

Report predicts growth for global sports medicine market

A Data Bridge Market Research report predicts the worldwide sports medicine market will reach $34.7 billion by 2024 with an 8 -More- 

DNAmito enters development, OEM deal with Varian Medical Systems

A development and original equipment manufacturer deal has been reached by DNAmito and Varian Medical Systems to enable integ -More- 

Tekcapital unit plans up to $13.2M IPO on AIM market

Belluscura, a wholly owned subsidiary of intellectual property investment group Tekcapital, announced plans to launch an init -More- 

Merit Medical enters $100M deal to buy biopsy products from BD

Merit Medical Systems agreed to pay $100 million for Becton Dickinson's soft-tissue core-needle biopsy devices, including the -More- 

Teleflex looks to raise about $491.2M in senior notes offering

A public offering of senior notes due in 2027 was announced by Teleflex in hopes of raising about $500 million.  -More- 

Thursday 16th November 2017

DxTech Summit

Dec.  -More- 

3rd-party review framework for tumor profiling tests unveiled by FDA

A review framework for next generation sequencing-based tumor profiling tests was unveiled by the FDA after announcing it cle -More- 

House passes compromise on Pentagon drug, device approval provision

A bill that would allow expedited FDA approval of medical devices and drugs for use on the battlefield by expanding the agenc -More- 

Quick Search

News Quicklinks